Atopic dermatitis in pregnancy: Current status and challenges

Obstetrical and Gynecological Survey

Volumn 66, Issue 10, 2011, Pages 654-663

  Koutroulis, Ioannis ^a   Papoutsis, John ^b   Kroumpouzos, George ^c  

^a FLUSHING HOSPITAL MEDICAL CENTER   (United States)

^b TEI of Antikalamos   (Greece)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CEPHALOSPORIN; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; CYCLOSPORIN; DIPHENHYDRAMINE; EMOLLIENT AGENT; ERYTHROMYCIN ETHYLSUCCINATE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; LORATADINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PIMECROLIMUS; PREDNISOLONE; PREDNISONE; PSORALEN; STEROID; TACROLIMUS;

ABORTION; ATOPIC DERMATITIS; BACTERIAL INFECTION; BLOOD TOXICITY; CLEFT LIP; CLEFT LIP PALATE; CLEFT PALATE; CLINICAL FEATURE; CONGENITAL MALFORMATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG POTENCY; DRUG SAFETY; ECZEMA; EPIDEMIOLOGICAL DATA; FETUS MALFORMATION; HERPES SIMPLEX; HUMAN; INTRAUTERINE GROWTH RETARDATION; LEUKOPENIA; LIVER TOXICITY; LOW BIRTH WEIGHT; NEPHROTOXICITY; NEWBORN DISEASE; PATHOGENESIS; PREGNANCY; PREMATURE LABOR; PREMATURITY; PREVALENCE; PROGNOSIS; PUERPERIUM; RETROLENTAL FIBROPLASIA; REVIEW; SPONTANEOUS ABORTION; SUPERINFECTION; THROMBOCYTOPENIA; ULTRAVIOLET B RADIATION;

DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREVALENCE; PROGNOSIS;

EID: 83055169740     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31823a0908     Document Type: Review

References (55)

1. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol. 2001;45:1-19. (Pubitemid 32655686)
2. Kroumpouzos G, Cohen LM. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol. 2003;188:1083-1092. (Pubitemid 36530068)
3. Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol. 1983;8:405-412. (Pubitemid 13147760)
4. Shornick JK. Dermatoses of pregnancy. Semin Cutan Med Surg. 1998;17:172-181. (Pubitemid 28435978)
5. Ambros-Rudolph CM, Mü llegger RR, Vaughan-Jones SA, et al. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54:395-404. (Pubitemid 43243440)
6. Cohen LM, Kroumpouzos G. Pruritic dermatoses of pregnancy: to lump or to split? J Am Acad Dermatol. 2007;56:708-709. (Pubitemid 46400193)
7. Ingber A. Atopic eruption of pregnancy. JEADV. 2010;24:974.
8. Kemmett D, Tidman MJ. The influence of menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol. 1991; 125:59-61.
9. Vaughan Jones SA, Hern S, Nelson-Piercy C, et al. A prospective study of 200 women with dermatoses of pregnancy correlating the clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999;141:71-81. (Pubitemid 29333696)
10. Cho S, Kim HJ, Oh SH, et al. The influence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann Dematol. 2010;22180-22185.
11. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Derm Venereol. 1980;92(S):44-47.
12. Williams HC, Burney PGJ, Hay RJ, et al. The U.K. Working Party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131:383-396. (Pubitemid 24290226)
13. Weatherhead S, Robson SC, Reynolds NJ. Eczema in pregnancy. BMJ. 2007;335:152-154. (Pubitemid 47172236)
14. Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49:1088-1095. (Pubitemid 37475483)
15. Latta RA, Baker DA. Treatment of recurrent eczema herpeticum in pregnancy with acyclovir. Infect Dis Obstet Gynecol. 1996;4:239-242. (Pubitemid 27114331)
16. Moreno E, Macías E, Dá vila I, et al. Recurring eczema during pregnancy and after delivery due to sensitization caused by an ultrasound gel. Ultrasound Obstet Gynecol. 2009;34:120-121.
17. Kroumpouzos G. Intrahepatic cholestasis of pregnancy: what's new. JEADV. 2002;16:316-318. (Pubitemid 34918809)
18. Roger D, Vaillant L, Fignon A, et al. Specific pruritic dermatoses of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol. 1994;130:734-739. (Pubitemid 24182682)
19. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832-836. (Pubitemid 38608590)
20. Wuthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS. J Investig Allergol Clin Immunol. 2003; 13:1-5. (Pubitemid 36781516)
21. Brenninkmeijer EE, Spuls PI, Legierse CM, et al. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol. 2008;58:407-414. (Pubitemid 351226310)
22. Oppel T, Schuller E, Gunther S, et al. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol. 2000; 143:1193-1198. (Pubitemid 32052754)
23. Bos JD, Brenninkmeijer EE, Schram ME, et al. Atopic eczema or atopiform dermatitis. Exp Dermatol. 2010;19:325-331.
24. Brenninkmeijer EE, Schram ME, Leeflang MMG, et al. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol. 2008;158:754-765. (Pubitemid 351415721)
25. Kroumpouzos G. Specific dermatoses of pregnancy: advances and controversies. Expert Rev Dermatol. 2010;5:633-648.
26. Ekström AS, Nilsson C, Holmlund U, et al. IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy. Clin Exp Immunol. 2002;127: 274-282. (Pubitemid 34233933)
27. Løken MO, Jeansson S, Jenum PA, et al. Serum level of immunoglobulin E during pregnancy-does offspring sex matter? Paediatr Perinat Epidemiol. 2010;24:75-78.
28. Lin YC, Wen HJ, Lee YL, et al. Are maternal psychosocial factors associated with cord immunoglobulin E in addition to family atopic history and mother immunoglobulin E? Clin Exp Allergy. 2004;34:548-554.
29. Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1997;117:550-555. (Pubitemid 29398304)
30. Howarth PH. ABC of allergies. Pathogenic mechanisms: a rational basis for treatment. BMJ. 1998;316:758-761. (Pubitemid 28121081)
31. Parcels DA. Women's mental health nursing: depression, anxiety and stress during pregnancy. J Psychiatr Ment Health Nurs. 2010;17:813-820.
32. Chen W, Mempel M, Schober W, et al. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy. 2008;63:1418-1427.
33. Mathur S, Mathur RS, Goust JM, et al. Sex steroid hormones and circulating IgE levels. Clin Exp Immunol. 1977;30:403-407. (Pubitemid 8267978)
34. Hanifin JM. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol. 2009;129:320-322.
35. Papoutsis J, Kroumpouzos G. Dermatologic disorders. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: Normal and Problem Pregnancies. 5th ed. Philadelphia, PA: Churchill Livingstone; 2007;1178-1192.
36. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997;56:335-340. (Pubitemid 28035180)
37. Katz VL, Thorp JM Jr, Bowes WA Jr. Severe symmetric intrauterine growth retardation associated with the topical use of triamcinolone. Am J Obstet Gynecol. 1990;162:396-397. (Pubitemid 20068505)
38. Mahe A, Perret JL, Ly F, et al. The cosmetic use of skinlightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101:183-187. (Pubitemid 44835343)
39. Edwards MJ, Agho K, Attia J, et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet. 2003;120A:459-463. (Pubitemid 37063739)
40. Purohit DM, Ellison C, Zierler S, et al. Risk factors for retrolental fibroplasias: experience with 3,025 premature infants. Pediatrics. 1985;76:339-344. (Pubitemid 15242493)
41. Fitzsimons R, Greenberger PA, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol. 1986;78:349-353. (Pubitemid 16039642)
42. Gur C, Diav-Citrin O, Shechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18:93-101. (Pubitemid 38175451)
43. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 1999; 86:242-244. (Pubitemid 29465870)
44. Pradat P, Robert-Gnansia E, Di Tanna GL, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res (Part A): Clin Mol Teratol. 2003;67:968-970. (Pubitemid 38018036)
45. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385-392.
46. Rodíguez-Pinilla E, Martinez-Frías ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology. 1998;58:2-5.
47. Briggs GG, Freeman RK, Yaffe SJ. Cyclosporine. In: Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:450-454.
48. Lau RJ, Scott JR. Pregnancy following renal transplantation. Clin Obstet Gynecol. 1985;28:339-350. (Pubitemid 15058429)
49. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol. 2002;17:121-130. (Pubitemid 36067982)
50. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol. 1985;92:233-239. (Pubitemid 15146698)
51. Chi CC, Lee CW, Wojnarowska F, et al. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2009:CD007346.
52. Chi CC, Wang SH, Kirtschig G, et al. Systematic review of the safety of topical corticosteroids in pregnancy. J Am Acad Dermatol. 2010;62:694-705.
53. Kä llé n B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002;11:146-152. (Pubitemid 34836924)
54. Gabbe SG. Drug therapy in autoimmune disease. Clin Obstet Gynecol. 1987;26:635-641.
55. Tendron A, Decramer S, Justrabo E, et al. Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol. 2003;14: 3188-3196. (Pubitemid 37509294)